Molecularly imprinted polymers for drug delivery

Area of Science:

• Polymer Science
• Materials Science
• Pharmaceutical Technology

Background:

• Molecular imprinting technology (MIT) is emerging as a powerful tool in pharmaceutical development.
• Its application in drug delivery systems (DDS) and diagnostic sensors is gaining significant traction.
• MIT offers a unique approach to creating tailored materials for specific molecular recognition.

Purpose of the Study:

• To review the potential of molecular imprinting technology in developing advanced drug dosage forms.
• To highlight the advantages of MIPs in designing novel drug delivery systems (DDS) and diagnostic sensors.
• To discuss the adaptability of MIP synthesis for sensitive drugs and physiological tissues.

Main Methods:

• Review of existing literature on molecular imprinting technology in drug delivery.
• Analysis of different DDS approaches: rate-programmed, activation-modulated, and feedback-regulated.
• Discussion of MIP application for various administration routes (oral, ocular, transdermal) and in vivo substance trapping.

Main Results:

• MIPs demonstrate significant potential for creating effective drug dosage forms with controlled release profiles.
• MIP-based DDS can be designed for diverse administration routes and in vivo applications, including trapping undesired substances.
• The imprinting technique shows promise for accommodating unstable drug molecules, particularly peptides, and sensitive physiological tissues.

Conclusions:

• Molecular imprinting technology presents remarkable advantages for developing novel and efficient drug delivery systems.
• Adaptable synthesis procedures are crucial for creating biocompatible MIPs for sensitive drugs and tissues.
• Future prospects include further development of MIP-based DDS for enhanced therapeutic outcomes and diagnostic applications.